Skip to main content
メニュー
JP

Resource Center

Filters
Select resource types (2)
Select products & services
Select solutions
Active Filters (2)
Clear All
1 - 12 of 107 Results
Sort by: Best Match
Best Match
Title A-Z
Title Z-A
Filter & Sort
Article Icon   Article
Assessing nanomedicine delivery across the blood-brain barrier using pre-clinical in vivo imaging
Researchers discuss the rationalrationale behind utilizing various pre-clinical in vivo imaging techniques to explore the uptake of custom-designed nanomedicines at different stages of brain cancer.
Whitepaper Icon   Whitepaper
Get our White Paper about autoimmunity
A complete review on current and emerging therapeutic approaches for autoimmune diseases
Whitepaper Icon   Whitepaper
Chimeric Antigen Receptor (CAR) Natural Killer cells: a promising cell therapy strategy for cancer treatment
Featured in this white paper is information on NK cells and cytotoxicity, CAR NK cell therapy description, including genetic modification and CAR generation, and advantages, limitations, and clinical progress of CAR NK cell therapy.
Whitepaper Icon   Whitepaper
Download your white paper on data analysis methods
This white paper gives you tools for analyzing obtained experimental data such as 2nd messenger quantification for GPCR investigation and screening.
Whitepaper Icon   Whitepaper
Guidance for Ensuring Your VICTOR Nivo Multimode Plate Reader Complies with 21 CFR Part 11
With specific reference to the relevant paragraphs of 21 CFR Part 11, this document describes how the tools within the VICTOR Nivo Enhanced Security software facilitate compliance with this regulation.
Whitepaper Icon   Whitepaper
Meet the scientist: uncovering the pathways dictating evolution of lung cancer heterogeneity
Understanding why tumors evolve from a single cell to a heterogenous tissue could direct the development of new therapies.
Whitepaper Icon   Whitepaper
Murine NASH model could provide insights into NASH development and progression
Researchers explore a multidisciplinary approach to addressing current NAFLD and NASH challenges.
Whitepaper Icon   Whitepaper
Genetically engineered PDX models as patient avatars in preclinical evaluation of acute leukemias
Identifying therapeutic targets using gene silencing techniques in PDX models
Whitepaper Icon   Whitepaper
Research spotlight: new therapeutic targets focusing on aberrant lipid metabolism in Alzheimer’s disease
This whitepaper explores new therapeutic targets focusing on Aberrant Lipid Metabolism in Alzheimer's Disease
Article Icon   Article
Selective targeting of mHTT presents novel therapeutic approach to huntington's disease
Researchers have engineered zinc finger protein transcription factors (ZFP-TFs) to target the pathogenic CAG repeat and selectively lower mHTT as a therapeutic strategy.
Whitepaper Icon   Whitepaper
Guidance for ensuring your VICTOR Nivo multimode plate reader complies with 21 CFR Part 11
With specific reference to the relevant paragraphs of 21 CFR Part 11, this document describes how the tools within the VICTOR NivoTM Enhanced Security software facilitate compliance with this regulation.
Article Icon   Article
Research spotlight interview: the role of biomarkers in drug discovery for neurodegenerative disease
Researcher takes a multidisciplinary approach in defining early biomarkers of dementia.
resource-center-page-end-card-bg-illuminator.png
resource-center-page-end-card-bg-illuminator-mobile.png

Looking for technical documents?

Find the technical documents you need, ASAP, in our easy-to-search library.